{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:58:00Z","timestamp":1781895480775,"version":"3.54.5"},"reference-count":261,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University Grant Commission, New Delhi for financial assistance"},{"name":"Prof. Pandit Vidyasagar, Hon'ble Vice Chancellor, SRTM University Nanded"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Biophysics and Molecular Biology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.pbiomolbio.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T17:15:20Z","timestamp":1381857320000},"page":"333-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Targeting tumor micro-environment for design and development of\u00a0novel anti-angiogenic agents arresting tumor growth"],"prefix":"10.1016","volume":"113","author":[{"given":"Rajesh N.","family":"Gacche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan J.","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1097-0177(199905)215:1<12::AID-DVDY3>3.0.CO;2-N","article-title":"Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature","volume":"215","author":"Aase","year":"1999","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib2","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/jm049082i","article-title":"2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors","volume":"48","author":"Allegretti","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib3","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/1535-7163.MCT-12-0366","article-title":"Targeting TRAIL death receptor 4 with trivalent DR4 Atrime complexes","volume":"11","author":"Allen","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib4","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/sj.emboj.7601906","article-title":"Structural studies of neuropilin\/antibody complexes provide insights into semaphorin and VEGF binding","volume":"26","author":"Appleton","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib5","doi-asserted-by":"crossref","first-page":"12969","DOI":"10.1073\/pnas.93.23.12969","article-title":"An essential role for p300\/CBP in the cellular response to hypoxia","volume":"93","author":"Arany","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib6","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0960-894X(00)00441-8","article-title":"Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I","volume":"10","author":"Arnold","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib7","doi-asserted-by":"crossref","first-page":"9246","DOI":"10.1016\/S0021-9258(18)98342-0","article-title":"Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6","volume":"268","author":"Bach","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib8","first-page":"345","article-title":"Angiogenin, a potent mediator of angiogenesis. Biological, biochemical and structural properties","volume":"47","author":"Badet","year":"1993","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.immunol.15.1.675","article-title":"Human chemokines: an update","volume":"15","author":"Baggiolini","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0167-4838(87)90112-9","article-title":"On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors","volume":"16","author":"Bajaj","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib11","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1074\/jbc.271.11.6071","article-title":"Epidermal growth factor related peptides activate distinct subsets of ErbB receptors and differ in their biological activities","volume":"271","author":"Beerli","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.HYP.33.5.1185","article-title":"Proadrenomedullin N-terminal 20 peptide (PAMP), acting through PAMP(12\u201320)-sensitive receptors, inhibits Ca2+-dependent, agonist-stimulated secretion of human adrenal glands","volume":"33","author":"Belloni","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib14","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1073\/pnas.86.5.1573","article-title":"Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2","volume":"86","author":"Bicknell","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib15","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.bmcl.2004.02.101","article-title":"A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection","volume":"14","author":"Borhani","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1846706","article-title":"Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product","volume":"251","author":"Bottaro","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.CIR.103.4.549","article-title":"Interleukin-3 stimulates migration and proliferation of vascular smooth muscle cells: a potential role in atherogenesis","volume":"103","author":"Brizzi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/emboj\/21.5.1054","article-title":"Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur","volume":"21","author":"Brown","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A\u00a0conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib20","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2009.080597","article-title":"Alternative proteolytic processing of hepatocyte growth factor during wound repair","volume":"174","author":"Buchstein","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib21","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1074\/jbc.M109.063305","article-title":"Selection of a novel and highly specific tumor necrosis factor-a (TNF-a) antagonist: insight from the crystal structure of the antagonist-TNF-a complex","volume":"285","author":"Byla","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0955-2235(89)90038-0","article-title":"The solution structures of epidermal growth factor and transforming growth factor alpha","volume":"1","author":"Campbell","year":"1989","journal-title":"Prog. Growth Factor Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib23","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1021\/bi00494a032","article-title":"Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding","volume":"29","author":"Campion","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib24","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1111\/j.1742-4658.2006.05474.x","article-title":"Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue","volume":"273","author":"Canales","year":"2006","journal-title":"FEBS. J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib25","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1016\/S0021-9258(19)38983-5","article-title":"Epidermal growth factor","volume":"265","author":"Carpenter","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1128\/MCB.20.1.402-415.2000","article-title":"Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha","volume":"20","author":"Carrero","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib27","first-page":"647","article-title":"The latest advances in kidney diseases and related disorders","volume":"20","author":"Cases","year":"2007","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib28","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1046\/j.0014-2956.2001.02581.x","article-title":"Solution structure of the mEGF\/TGFa44250 chimeric growth factor","volume":"268","author":"Chamberlin","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1126\/science.1720571","article-title":"Identification of a competitive HGF antagonist encoded by an alternative transcript","volume":"254","author":"Chan","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib30","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1074\/jbc.M313237200","article-title":"The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1","volume":"279","author":"Christinger","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib31","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1002\/j.1460-2075.1991.tb04988.x","article-title":"Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation","volume":"10","author":"Clements","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib32","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1074\/jbc.271.2.736","article-title":"Interleukin 6 induces the expression of vascular endothelial growth factor","volume":"271","author":"Cohen","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib33","first-page":"7163","article-title":"Fibroblast growth factors are required for efficient tumor angiogenesis","volume":"60","author":"Compagni","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib34","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1073\/pnas.082121399","article-title":"Structural basis for Hif-1alpha\/CBP recognition in the cellular hypoxic response","volume":"99","author":"Dames","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1747-0285.2006.00356.x","article-title":"Peptide-based molecules in angiogenesis","volume":"67","author":"D'Andrea","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib36","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1073\/pnas.95.12.6941","article-title":"Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1a, a potent ligand for the HIV-1 \u201cfusin\u201d coreceptor","volume":"95","author":"Dealwis","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","article-title":"Expression, regulation and function of IGF-1, IGF-1R and IGF-1 binding proteins in blood vessels","volume":"24","author":"Delafontaine","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cytogfr.2005.04.004","article-title":"Molecular interactions of the IGF system","volume":"16","author":"Denley","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib39","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.4049\/jimmunol.163.4.2151","article-title":"Human IL-3 stimulates endothelial cell motility and promotes in\u00a0vivo new vessel formation","volume":"163","author":"Dentelli","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2009.01.044","article-title":"Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects","volume":"123","author":"Detoraki","year":"2009","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib41","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1158\/1535-7163.MCT-09-1134","article-title":"A\u00a0human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in\u00a0vitro and in\u00a0vivo","volume":"9","author":"Dransfield","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib42","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/1078-0432.CCR-08-1306","article-title":"Novel therapeutic inhibitors of the c-Met signaling pathway in cancer","volume":"15","author":"Eder","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2010.08.010","article-title":"Dynamics of endothelial cell behavior in sprouting angiogenesis","volume":"22","author":"Eilken","year":"2010","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib44","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1074\/jbc.C200644200","article-title":"Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1a","volume":"278","author":"Elkins","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib45","doi-asserted-by":"crossref","first-page":"8930","DOI":"10.1021\/bi010037b","article-title":"Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain","volume":"40","author":"Elleman","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib46","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.hoc.2004.06.002","article-title":"Epidermal growth factor receptor in tumor angiogenesis","volume":"18","author":"Ellis","year":"2004","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib47","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/1535-7163.MCT-05-0538","article-title":"The role of neuropilins in cancer","volume":"5","author":"Ellis","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib48","doi-asserted-by":"crossref","DOI":"10.1089\/ten.tea.2012.0653","article-title":"Stromal cell-derived factor-1 stimulates cell recruitment, vascularization and osteogenic differentiation","author":"Eman","year":"2013","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib49","first-page":"2126","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib50","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/S0021-9258(18)45874-7","article-title":"Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivation","volume":"267","author":"Engler","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib51","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/sj.onc.1201090","article-title":"Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia","volume":"14","author":"Enholm","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib52","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nrc1473","article-title":"The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies","volume":"4","author":"Epstein","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib53","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/0008-5472.CAN-03-0407","article-title":"Interleukin-1b regulates Angiopoietin-1 expression in human endothelial cells","volume":"64","author":"Fan","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib54","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.chembiol.2011.05.011","article-title":"The development of peptide-based tools for the analysis of angiogenesis","volume":"18","author":"Fedorova","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib55","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(03)00047-9","article-title":"EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization","volume":"11","author":"Ferguson","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib56","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1074\/jbc.M109.064618","article-title":"Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in\u00a0vivo fibroblast growth factor inhibitors","volume":"285","author":"Fern\u00e1ndez","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jcp.21706","article-title":"Transforming growth factor-beta 1 (TGFbeta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis","volume":"219","author":"Ferrari","year":"2009","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib58","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1021\/bi00184a010","article-title":"A\u00a0monoclonal antibody to human angiogenin. Inhibition of ribonucleolytic and angiogenic activities and localization of the antigenic epitope","volume":"33","author":"Fett","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib59","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1074\/jbc.M208550200","article-title":"Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats","volume":"278","author":"Fiedler","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib60","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/eji.1830221021","article-title":"Analysis of human\/mouse interleukin-6 hybrid proteins: both amino and carboxy termini of human interleukin-6 are required for in\u00a0vitro receptor binding","volume":"22","author":"Fiorillo","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib61","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1432-1033.1993.tb17605.x","article-title":"Involvement of the Arg179 in the active site of human IL-6","volume":"211","author":"Fontaine","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib62","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib63","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ncb1440","article-title":"SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production","volume":"8","author":"Friedmann","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib64","doi-asserted-by":"crossref","first-page":"26690","DOI":"10.1016\/S0021-9258(19)61431-6","article-title":"The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1","volume":"275","author":"Fuh","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib65","doi-asserted-by":"crossref","first-page":"11197","DOI":"10.1074\/jbc.273.18.11197","article-title":"Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor","volume":"273","author":"Fuh","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12013-011-9251-z","article-title":"Evaluation of selected flavonoids as antiangiogenic, anticancer, and radical scavenging agents: an experimental and in silico analysis","volume":"61","author":"Gacche","year":"2011","journal-title":"Cell. Biochem. Biophys."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejps.2009.10.008","article-title":"Effect of hydroxyl substitution of flavone on angiogenesis and free radical scavenging activities: a structure-activity relationship studies using computational tools","volume":"39","author":"Gacche","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib68","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1139\/o97-091","article-title":"Fibroblast growth factors and their receptors","volume":"75","author":"Galzie","year":"1997","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib69","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/07357909309024841","article-title":"Clinical results with recombinant human interleukin-3","volume":"11","author":"Ganser","year":"1993","journal-title":"Cancer Invest"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib70","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14728214.12.4.627","article-title":"Current and emerging drugs for idiopathic pulmonary fibrosis","volume":"12","author":"Gharaee-Kermani","year":"2007","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib71","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1073\/pnas.86.15.5844","article-title":"Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement","volume":"86","author":"Gherardi","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib72","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1128\/MCB.10.10.5496","article-title":"A\u00a0small v-sis\/platelet-derived growth factor (PDGF) B-protein domain in which subtle conformational changes abrogate PDGF receptor interaction and transforming activity","volume":"10","author":"Giese","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib73","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2174\/156802607781696819","article-title":"A\u00a0comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development","volume":"7","author":"Gill","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.pbiomolbio.2013.10.001_bib74","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib75","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1158\/1535-7163.MCT-08-0510","article-title":"A\u00a0RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth","volume":"7","author":"Greenberger","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib76","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08977199409010997","article-title":"Structure-function relationships for the EGF\/TGF-family of mitogens","volume":"11","author":"Groenen","year":"1994","journal-title":"Growth Factors"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib77","doi-asserted-by":"crossref","first-page":"18069","DOI":"10.1074\/jbc.M201681200","article-title":"Characterization of neuropilin- 1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165","volume":"277","author":"Gu","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib78","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jmb.2009.10.072","article-title":"Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme","volume":"395","author":"Guo","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib79","first-page":"2808","article-title":"Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density","volume":"3","author":"Hague","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib80","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/me.2002-0438","article-title":"Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells","volume":"17","author":"Hall","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib81","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1021\/bi00149a036","article-title":"Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin","volume":"31","author":"Hallahan","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib82","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1073\/pnas.88.6.2222","article-title":"Dual site model for the organogenic activity of angiogenin","volume":"88","author":"Hallahan","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib83","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib84","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1006\/jmbi.1994.1312","article-title":"Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains","volume":"238","author":"Harpaz","year":"1994","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib85","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/08977199308991586","article-title":"A\u00a0heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta","volume":"9","author":"Hauser","year":"1993","journal-title":"Growth Factors"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib86","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0006-291X(87)91011-4","article-title":"An in\u00a0vivo model for study of the angiogenic effects of basic fibroblast growth factor","volume":"147","author":"Hayek","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jri.2005.07.001","article-title":"FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis","volume":"67","author":"Hayrabedyan","year":"2005","journal-title":"J.\u00a0Reprod. Immunol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib88","doi-asserted-by":"crossref","first-page":"18989","DOI":"10.1016\/S0021-9258(18)55160-7","article-title":"Scanning mutagenesis of IL-8 identifies a cluster of residues required for receptor binding","volume":"266","author":"H\u00e9bert","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib90","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/jm061107l","article-title":"Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor","volume":"50","author":"Hodous","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib91","doi-asserted-by":"crossref","first-page":"e31298","DOI":"10.1371\/journal.pone.0031298","article-title":"New binding mode to TNF-alpha revealed by ubiquitin-based artificial binding protein","volume":"7","author":"Hoffmann","year":"2012","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib92","doi-asserted-by":"crossref","first-page":"10482","DOI":"10.1021\/bi026151r","article-title":"Guest-host crosstalk in an angiogenin-Rnase a chimeric protein","volume":"41","author":"Holloway","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib93","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/prep.2001.1402","article-title":"Solution studies of recombinant human stromal-cell-derived factor-1","volume":"21","author":"Holmes","year":"2001","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib94","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7164\/antibiotics.52.485","article-title":"Effect of thiazinotrienomycin B, an ansamycin antibiotic, on the function of epidermal growth factor receptor in human stomach tumor cells","volume":"52","author":"Hosokawa","year":"1999","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib95","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1073\/pnas.94.6.2204","article-title":"A\u00a0putative angiogenin receptor in angiogenin-responsive human endothelial cells","volume":"94","author":"Hu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib96","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.bmcl.2008.02.070","article-title":"Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors","volume":"18","author":"Huang","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0002-9440(10)64164-8","article-title":"Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma","volume":"161","author":"Huang","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib98","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-3495(03)74840-1","article-title":"Molecular dynamics simulations on SDF-1a: binding with CXCR4 receptor","volume":"84","author":"Huang","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib99","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2443.2000.00376.x","article-title":"Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation","volume":"5","author":"Ikuta","year":"2000","journal-title":"Genes Cells"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.0000138018.61065.d1","article-title":"Angiogenic effects of adrenomedullin in ischemia and tumor growth","volume":"95","author":"Iimuro","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib101","first-page":"2104","article-title":"Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer","volume":"6","author":"Inoue","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib102","first-page":"468","article-title":"Drug evaluation: Nilotinib \u2013 a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyond","volume":"10","author":"Jabbour","year":"2007","journal-title":"IDrugs"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib103","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1021\/bi961553i","article-title":"Structural changes in insulin-like growth factor IGF I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor","volume":"36","author":"Jansson","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib104","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1021\/jm901755g","article-title":"Small molecule inhibitors of the Neuropilin-1 vascular endothelial growth factor a (VEGF-A) interaction","volume":"53","author":"Jarvis","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0167-4889(92)90136-Y","article-title":"Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction","volume":"1135","author":"Jaye","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib106","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.0806517","article-title":"Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis","volume":"81","author":"Jeon","year":"2007","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib107","doi-asserted-by":"crossref","first-page":"19253","DOI":"10.1074\/jbc.272.31.19253","article-title":"Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension","volume":"272","author":"Jiang","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60821-0","article-title":"Structural and functional diversity in the FGF receptor multigene family","volume":"60","author":"Johnson","year":"1993","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(00)81092-2","article-title":"Active and inactive protein kinases: structural basis for regulation","volume":"85","author":"Johnson","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","article-title":"A\u00a0novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases","volume":"15","author":"Joukov","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/13543784.17.1.43","article-title":"Therapeutic applications of aptamers","volume":"17","author":"Kaur","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib112","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/01.CIR.0000117231.40057.6D","article-title":"Endogenous adrenomedullin protects against vascular response to injury in mice","volume":"109","author":"Kawai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib113","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/14728214.13.3.511","article-title":"Emerging drugs for chemotherapy-induced mucositis","volume":"3","author":"Keefe","year":"2008","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib114","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","article-title":"The effects of insulin-like growth factors on tumorigenesis and neoplastic growth","volume":"21","author":"Khandwala","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib115","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1046\/j.1432-1033.2002.02877.x","article-title":"Chimeric receptor analyses of the interactions of the ectodomains of ErbB-1 with epidermal growth factor and of those of ErbB-4 with neuregulin","volume":"269","author":"Kim","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib116","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1096\/fj.02-1209fje","article-title":"Angiogenic role of adrenomedullin through activation of Akt, mitogenactivated protein kinase, and focal adhesion kinase in endothelial cells","volume":"17","author":"Kim","year":"2003","journal-title":"FASEB. J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib117","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.pbiomolbio.2013.10.001_bib118","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1172\/JCI66171","article-title":"Are epsins a therapeutic target for tumor angiogenesis?","volume":"122","author":"Klauber-DeMore","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib119","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-07-0463","article-title":"Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha","volume":"7","author":"Koh","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib121","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0167-4838(92)90245-9","article-title":"A\u00a0site directed mutagenesis study on the role of isoleucine-23 of human epidermal growth factor in the receptor binding","volume":"1120","author":"Koide","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib122","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-5793(92)80279-P","article-title":"Recognition of an antiparallel beta-sheet structure of human epidermal growth factor by its receptor. Site-directed mutagenesis studies of Ala-30 and Asn-32","volume":"302","author":"Koide","year":"1992","journal-title":"FEBS. Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-5793(93)80958-W","article-title":"Proteolytic processing of the hepatocyte growth factor\/scatter factor receptor by furin","volume":"328","author":"Komada","year":"1993","journal-title":"FEBS. Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib124","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2004.06.013","article-title":"The Sema domain of Met is necessary for receptor dimerization and activation","volume":"6","author":"Kong","year":"2004","journal-title":"Cancer Cell."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib125","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1158\/1078-0432.CCR-04-2466","article-title":"Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignancies","volume":"11","author":"Kuenen","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib126","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/82146","article-title":"Suppression of tumor growth through disruption of hypoxia-inducible transcription","volume":"6","author":"Kung","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib127","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor","volume":"16","author":"Lando","year":"2002","journal-title":"Genes. Dev."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib128","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.2163109","article-title":"Molecular localization of the transforming and secretory properties of PDGF A and PDGF B","volume":"248","author":"LaRochelle","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/humrep\/dei308","article-title":"Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppress angiogenesis and vessel maturation in endometriotic lesions","volume":"21","author":"Laschke","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0969-2126(02)00941-3","article-title":"Crystal structure of the human Neuropilin-1 b1 domain","volume":"11","author":"Lee","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jmb.2009.08.026","article-title":"The interaction between thermodynamic stability and buried free cysteines in regulating the functional half-life of fibroblast growth factor-1","volume":"393","author":"Lee","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib132","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0968-0004(94)90130-9","article-title":"Regulation of signal transduction and signal diversity by receptor oligomerization","volume":"19","author":"Lemmon","year":"1994","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib133","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1006\/jmbi.1998.2378","article-title":"Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth","volume":"285","author":"Leonidas","year":"1999","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib134","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi015768q","article-title":"Crystallographic studies on the role of the C-terminal segment of human angiogenin in defining enzymatic potency","volume":"41","author":"Leonidas","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib135","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2010-08-301549","article-title":"Structural determinants of vascular endothelial growth factor-D receptor binding and specificity","volume":"117","author":"Lepp\u00e4nen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib136","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1073\/pnas.0914318107","article-title":"Structural determinants of growth factor binding and specificity by VEGF receptor 2","volume":"107","author":"Lepp\u00e4nen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib137","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib138","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/0008-5472.CAN-08-1565","article-title":"Low levels of tumor necrosis factor a increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib139","first-page":"913","article-title":"VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats","volume":"118","author":"Li","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib140","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1074\/jbc.C600277200","article-title":"Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth","volume":"282","author":"Li","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib141","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1093\/emboj\/20.20.5543","article-title":"Crystal structures of NK1-heparin complexes reveal the basis of NK1 activity and enable engineering of potent agonists of the MET receptor","volume":"20","author":"Lietha","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib142","doi-asserted-by":"crossref","first-page":"23986","DOI":"10.1074\/jbc.M100700200","article-title":"Real, time kinetics of insulin like growth factor II (IGF-II) interaction with the IGF-II\/mannose 6-phosphate receptor: the effects of domain 13 and pH","volume":"276","author":"Linnell","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib143","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ijc.20871","article-title":"Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in\u00a0vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1","volume":"115","author":"Loeffler","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib144","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/j.1460-2075.1992.tb05315.x","article-title":"Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding","volume":"11","author":"Lokker","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib145","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/pro.5560060309","article-title":"Monomeric variants of IL-8: effects of sidechain substitutions and solution conditions upon dimer formation","volume":"6","author":"Lowman","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib146","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1006\/jmbi.1998.1977","article-title":"Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas","volume":"281","author":"Lozano","year":"1998","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib147","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1128\/MCB.00742-10","article-title":"Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor","volume":"30","author":"Lu","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib148","doi-asserted-by":"crossref","first-page":"34913","DOI":"10.1074\/jbc.M102874200","article-title":"Crystal structure of human epidermal growth factor and its dimerization","volume":"276","author":"Lu","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib149","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/bip.20418","article-title":"NMR conformational analysis of proadrenomedullin N-terminal 20 peptide, a proangiogenic factor involved in tumor growth","volume":"81","author":"Lucyk","year":"2006","journal-title":"Biopolymers"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib150","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1016\/j.bmcl.2009.10.001","article-title":"Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in\u00a0vitro and in\u00a0vivo","volume":"19","author":"Luke","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib151","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2005.06.021","article-title":"Functions of CXCL12 and CXCR4 in breast cancer","volume":"238","author":"Luker","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib152","doi-asserted-by":"crossref","first-page":"43560","DOI":"10.1074\/jbc.M408510200","article-title":"The interactions of hepatocyte growth factor\/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay","volume":"42","author":"Lyon","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib153","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in\u00a0vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib154","doi-asserted-by":"crossref","first-page":"21217","DOI":"10.1074\/jbc.274.30.21217","article-title":"Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1","volume":"274","author":"Makinen","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/17460441.3.10.1189","article-title":"Design and development of antisense drugs","volume":"3","author":"Malik","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib156","doi-asserted-by":"crossref","first-page":"24818","DOI":"10.1074\/jbc.M200730200","article-title":"Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain","volume":"277","author":"Mamluk","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib157","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib158","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1158\/0008-5472.CAN-04-0103","article-title":"Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth","volume":"64","author":"Mart\u00ednez","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib159","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1016\/S0021-9258(17)43959-7","article-title":"Epidermal growth factor-like transforming growth factor 11. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells","volume":"258","author":"Massague","year":"1983","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib160","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S1359-6446(01)01939-0","article-title":"Tumor angiogenesis as a therapeutic target","volume":"6","author":"Matter","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib161","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1247\/csf.25.85","article-title":"The pleiotropic effects of fibroblast growth factor receptors in mammalian development","volume":"25","author":"McIntosh","year":"2000","journal-title":"Cell. Struct. Funct."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib162","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib163","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1074\/jbc.M109.066357","article-title":"The heterohexameric complex structure, a component in the non-classical pathway for fibroblast growth factor 1 (FGF1) secretion","volume":"285","author":"Mohan","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib164","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1006\/bbrc.1994.2391","article-title":"Identification of the nucleolar targeting signal of human angiogenin","volume":"203","author":"Moroianu","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib165","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1073\/pnas.91.5.1677","article-title":"Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity","volume":"91","author":"Moroianu","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib166","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0969-2126(98)00116-6","article-title":"VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface","volume":"6","author":"Muller","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib167","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1006\/cyto.1998.0465","article-title":"CXC chemokine receptor expression on human endothelial cells","volume":"11","author":"Murdoch","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib168","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/prot.22666","article-title":"Heterologous quaternary structure of CXCL12 and its relationship to the CC chemokine family","volume":"78","author":"Murphy","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib169","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0021-9150(92)90273-J","article-title":"Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells","volume":"92","author":"Nakao-Hayashi","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib170","doi-asserted-by":"crossref","first-page":"D781","DOI":"10.2741\/A321","article-title":"FGF signaling in skeletal development","volume":"3","author":"Naski","year":"1998","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib171","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1345\/aph.1G387","article-title":"Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors","volume":"40","author":"Nelson","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6602832","article-title":"Adrenomedullin and tumour angiogenesis","volume":"94","author":"Nikitenko","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib173","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/molehr\/6.9.811","article-title":"Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium","volume":"6","author":"Nikitenko","year":"2000","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib174","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1096\/fj.02-0993fje","article-title":"Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia","volume":"17","author":"Nikitenko","year":"2003","journal-title":"FASEB. J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib175","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/sj.onc.1205374","article-title":"Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis","volume":"21","author":"Oehler","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib176","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0092-8674(02)00963-7","article-title":"Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains","volume":"110","author":"Ogiso","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib177","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ijc.10282","article-title":"Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody","volume":"98","author":"Olson","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib178","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1073\/pnas.92.2.442","article-title":"Angiogenin antagonists prevent tumor growth in\u00a0vivo","volume":"92","author":"Olson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib179","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib180","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","article-title":"Tumor imaging using a picomolar affinity HER2 binding affibody molecule","volume":"66","author":"Orlova","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib181","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","article-title":"Receptor specificity of the fibroblast growth factor family","volume":"271","author":"Ornitz","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib182","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1128\/MCB.20.6.2055-2065.2000","article-title":"Disassociation of met-mediated biological responses in\u00a0vivo: the natural hepatocyte growth factor\/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis","volume":"20","author":"Otsuka","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib183","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"Overington","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib184","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1021\/bi970593z","article-title":"Distinct but overlapping epitopes for the interaction of RANTES with CCR1, CCR3 and CCR5","volume":"36","author":"Pakianathan","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib185","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in\u00a0vitro and in\u00a0vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","volume":"269","author":"Park","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib186","first-page":"725","article-title":"Angiogenin: involvement in angiogenesis and tumour growth","volume":"88","author":"Pavlov","year":"2001","journal-title":"Bull Cancer"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib187","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/jm0580297","article-title":"Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors","volume":"49","author":"Peifer","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib188","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/bip.21700","article-title":"Structure of micelle-bound adrenomedullin: a first step toward the analysis of its interactions with receptors and small molecules","volume":"97","author":"P\u00e9rez-Castells","year":"2012","journal-title":"Biopolymers"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib189","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/jmbi.1996.0631","article-title":"Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog","volume":"264","author":"Pineda-Lucena","year":"1996","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/14728210802676278","article-title":"Emerging therapies for multiple myeloma","volume":"14","author":"Podar","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib191","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib192","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1074\/jbc.272.17.11205","article-title":"Activation of hypoxia-inducible factor-1, definition of regulatory domains within the alpha subunit","volume":"272","author":"Pugh","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib193","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1179\/016164104225013851","article-title":"The multifunctional role of IGF-1 in peripheral nerve regeneration","volume":"26","author":"Rabinovsky","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib194","doi-asserted-by":"crossref","first-page":"17114","DOI":"10.1074\/jbc.M301728200","article-title":"Platelet-derived growth factor (PDGF)-C, a PDGF family member with a vascular endothelial growth factor-like structure","volume":"278","author":"Reigstad","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cvr\/cvq045","article-title":"Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling","volume":"86","author":"Rey","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.pbiomolbio.2013.10.001_bib196","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1593\/neo.121962","article-title":"The role of angiogenesis in human non-Hodgkin lymphomas","volume":"15","author":"Ribatti","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib197","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1038\/sj.onc.1206789","article-title":"Vinblastine inhibits the angiogenic response induced by adrenomedullin in\u00a0vitro and in\u00a0vivo","volume":"22","author":"Ribatti","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib198","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1074\/jbc.270.4.1612","article-title":"Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor","volume":"270","author":"Richter","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib199","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumor progression","volume":"62","author":"Roskoski","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(86)90733-6","article-title":"The biology of platelet-derived growth factor","volume":"46","author":"Ross","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib201","first-page":"782020","article-title":"Targeting angiogenesis for controlling neuroblastoma","volume":"2012","author":"Roy Choudhury","year":"2012","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib202","first-page":"267","article-title":"The chemopreventive agent oltipraz possesses potent antiangiogenic activity in\u00a0vitro, ex\u00a0vivo, and in\u00a0vivo and inhibits tumor xenograft growth","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib203","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/prot.21350","article-title":"Crystal structure of recombinant human stromal cell-derived factor-1a","volume":"67","author":"Ryu","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib204","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1016\/j.bmcl.2009.06.027","article-title":"Structure-activity relationship of novel phenylacetic CXCR1 inhibitors","volume":"19","author":"Sablone","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib205","doi-asserted-by":"crossref","first-page":"43854","DOI":"10.1074\/jbc.M405392200","article-title":"Heparan sulfate\/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)\/CXCL12 against proteolysis induced by CD26\/dipeptidyl peptidase IV","volume":"279","author":"Sadir","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib206","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.169.1.469","article-title":"Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in\u00a0vivo analysis of tumor-stromal interaction","volume":"169","author":"Saijo","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib207","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1006\/jmbi.1993.1075","article-title":"High-resolution three-dimensional structure of ribonuclease A in solution by nuclear magnetic resonance spectroscopy","volume":"229","author":"Santoro","year":"1993","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib208","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1158\/1078-0432.CCR-07-1466","article-title":"A\u00a0phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors","volume":"14","author":"Sarker","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib209","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/excr.1993.1028","article-title":"Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in\u00a0vitro","volume":"204","author":"Sato","year":"1993","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0092-8674(95)90112-4","article-title":"Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?","volume":"83","author":"Schlessinger","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib211","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","article-title":"Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization","volume":"6","author":"Schlessinger","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib212","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","article-title":"Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis","volume":"141","author":"Seghezzi","year":"1998","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib213","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib214","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1021\/bi00360a008","article-title":"Characteristic ribonucleolytic activity of human angiogenin","volume":"25","author":"Shapiro","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib215","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/bi00390a037","article-title":"Isolation of angiogenin from normal human plasma","volume":"26","author":"Shapiro","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib216","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1021\/bi00444a038","article-title":"Site-directed mutagenesis of histidine-13 and histidine-1 14 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis","volume":"28","author":"Shapiro","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib217","doi-asserted-by":"crossref","first-page":"11307","DOI":"10.1073\/pnas.1000806107","article-title":"Structures of a platelet-derived growth factor\/propeptide complex and a platelet-derived growth factor\/receptor complex","volume":"107","author":"Shima","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib218","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/hc4101.097111","article-title":"Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene","volume":"104","author":"Shindo","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib219","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.str.2004.11.009","article-title":"Structural basis for the regulation of insulin-like growth factors by IGF binding proteins","volume":"13","author":"Siwanowicz","year":"2005","journal-title":"Structure"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib220","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A\u00a0pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib221","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","article-title":"Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor","volume":"92","author":"Soker","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib222","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1073\/pnas.89.6.2232","article-title":"Angiogenin supports endothelial and fibroblast cell adhesion","volume":"89","author":"Soncin","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib223","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0092-8674(94)90032-9","article-title":"Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation","volume":"79","author":"Spivak-Kroizman","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib224","doi-asserted-by":"crossref","first-page":"32127","DOI":"10.1074\/jbc.274.45.32127","article-title":"Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers","volume":"274","author":"Stacker","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib225","doi-asserted-by":"crossref","first-page":"10080","DOI":"10.1073\/pnas.94.19.10080","article-title":"Structural mimicry of a native protein by a minimized binding domain","volume":"94","author":"Starovasnik","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib226","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1016\/S0021-9258(18)82179-2","article-title":"The functional importance of hydrophobicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding","volume":"268","author":"Tadaki","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib227","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/carcin\/20.6.957","article-title":"Hepatocyte growth factor is an invasion\/migration factor of rat urothelial carcinoma cells in\u00a0vitro","volume":"20","author":"Tamatani","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib228","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: molecular mechanisms and future promise","volume":"140","author":"Tammela","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib229","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature07083","article-title":"Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation","volume":"454","author":"Tammela","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ijc.11059","article-title":"Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence","volume":"105","author":"Taylor","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib231","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.leu.2403224","article-title":"Interleukin-3 receptor in acute leukemia","volume":"18","author":"Testa","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib232","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jasms.2007.11.003","article-title":"Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation","volume":"19","author":"Thevis","year":"2008","journal-title":"J.\u00a0Am. Soc. Mass. Spectrom."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib233","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1073\/pnas.1005183107","article-title":"Structural basis for agonism and antagonism of hepatocyte growth factor","volume":"107","author":"Tolberta","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib234","doi-asserted-by":"crossref","first-page":"30274","DOI":"10.1016\/S0021-9258(18)43808-2","article-title":"Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment","volume":"269","author":"Tschesche","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib235","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1128\/MCB.16.10.5276","article-title":"A\u00a0hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor\/neuregulin and epidermal growth factor","volume":"16","author":"Tzahar","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib236","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1021\/bi970227f","article-title":"Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity","volume":"36","author":"Van de Poll","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib237","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0083-6729(00)59005-0","article-title":"The EGF domain: requirements for binding to receptors of the ErbB family","volume":"59","author":"Van Zoelen","year":"2000","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib238","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.0700043104","article-title":"Structural basis for ligand and heparin binding to neuropilin B domains","volume":"104","author":"Vander Kooi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib239","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/prot.340120103","article-title":"Functional implications of interleukin-1 beta based on the three-dimensional structure","volume":"12","author":"Veerapandian","year":"1992","journal-title":"Proteins"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/scbi.1998.0091","article-title":"VEGFs, receptors and angiogenesis","volume":"9","author":"Veikkola","year":"1999","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib241","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jmb.2006.04.052","article-title":"Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1[alpha] (SDF-1[alpha]\/CXCL12)","volume":"359","author":"Veldkamp","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib242","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/386190a0","article-title":"Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta","volume":"386","author":"Vigers","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib243","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib244","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/prot.340220207","article-title":"Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor","volume":"22","author":"Ward","year":"1995","journal-title":"Proteins"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib245","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib246","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/mgme.1999.2920","article-title":"Novel aspects of the insulin-like growth factor binding proteins","volume":"68","author":"Wetterau","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib247","doi-asserted-by":"crossref","first-page":"31928","DOI":"10.1074\/jbc.M109.025304","article-title":"High resolution NMR-based model for the structure of a scFv-IL-1beta complex potential for NMR as a key tool in therapeutic antibody design and development","volume":"284","author":"Wilkinson","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib248","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1074\/jbc.271.16.9579","article-title":"Mutagenesis studies of IL-8. Identification of a second epitope involved in receptor binding","volume":"271","author":"Williams","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib249","doi-asserted-by":"crossref","first-page":"39114","DOI":"10.1074\/jbc.M305603200","article-title":"Structural analysis of an epidermal growth factor\/transforming growth factor-alpha chimera with unique ErbB binding specificity","volume":"278","author":"Wingens","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib250","doi-asserted-by":"crossref","first-page":"18514","DOI":"10.1074\/jbc.273.29.18514","article-title":"Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2","volume":"273","author":"Witzenbichler","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib251","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/bi00408a010","article-title":"Structure of phosphate-free ribonuclease A refined at 1.26 A","volume":"27","author":"Wlodawer","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib252","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1158\/0008-5472.CAN-04-0934","article-title":"VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in\u00a0vivo effect on angiogenesis and endogenous protein expression","volume":"64","author":"Woolard","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib253","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clinthera.2008.01.014","article-title":"Panitumumab: human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer","volume":"30","author":"Wu","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib254","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood-2007-12-128215","article-title":"Interleukin-3 promotes expansion of hemopoietic-derived CD45+ angiogenic cells and their arterial commitment via STAT5 activation","volume":"112","author":"Zeoli","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib255","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1093\/emboj\/20.14.3638","article-title":"The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5","volume":"20","author":"Zeslawski","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib256","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.0813061106","article-title":"VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib257","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.onc.1201768","article-title":"PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium","volume":"16","author":"Zhao","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib258","doi-asserted-by":"crossref","first-page":"D1128","DOI":"10.1093\/nar\/gkr797","article-title":"Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery","volume":"40","author":"Zhu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib259","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0960-894X(96)00601-4","article-title":"Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives","volume":"7","author":"Zimmermann","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib260","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0960-894X(96)00197-7","article-title":"Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and highly selective PDGF-receptor autophosphorylation inhibitors","volume":"6","author":"Zimmermann","year":"1996","journal-title":"Med. Chem. Let"},{"key":"10.1016\/j.pbiomolbio.2013.10.001_bib261","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-0115(03)00037-5","article-title":"Adrenomedullin and cancer","volume":"112","author":"Zudaire","year":"2003","journal-title":"Regul. Pept."}],"container-title":["Progress in Biophysics and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610713001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610713001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T10:22:16Z","timestamp":1688552536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079610713001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":261,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0079610713001004"],"URL":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2013.10.001","relation":{},"ISSN":["0079-6107"],"issn-type":[{"value":"0079-6107","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting tumor micro-environment for design and development of\u00a0novel anti-angiogenic agents arresting tumor growth","name":"articletitle","label":"Article Title"},{"value":"Progress in Biophysics and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}